← Back to Search

Electronic Alert System for Sepsis (SEPTIC-ED Trial)

N/A
Waitlist Available
Led By Jason S Adelman, MD, MS
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
does not have an active order for "comfort measures only"
age > 18 years-old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 90 days
Awards & highlights

SEPTIC-ED Trial Summary

This trial tests if nurse and prescribing clinician alerts can help reduce time to sepsis treatment for patients in the ED.

Who is the study for?
This trial is for adults over 18 in the emergency department who meet criteria for systemic inflammatory response syndrome (SIRS) but aren't pregnant, haven't tested positive for COVID-19 recently, and aren't on comfort-only care. It excludes those already receiving sepsis treatment or enrolled in the SEPTIC study.Check my eligibility
What is being tested?
The study tests if electronic alerts to nurses and/or prescribing clinicians can speed up sepsis treatment. Patients are randomly placed into one of four groups: no alerts, nurse-only alerts, clinician-only alerts, or both nurse and clinician alerts.See study design
What are the potential side effects?
Since this trial involves electronic prompts rather than medications or procedures, traditional side effects are not a concern. However, there may be impacts on workflow or care delivery processes.

SEPTIC-ED Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am not under care for comfort measures only.
Select...
I am older than 18 years.

SEPTIC-ED Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 90 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of patients treated with Surviving Sepsis Campaign (SSC) hour-1 bundle
Secondary outcome measures
Adverse antibiotic events
Median number of days of hospitalization
Number of positive blood cultures
+14 more

SEPTIC-ED Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Prescribing clinician alertExperimental Treatment1 Intervention
Participants will receive physician alert.
Group II: Nurse alert and prescribing clinician alertExperimental Treatment2 Interventions
Participants will receive physician alert and RN alert.
Group III: Nurse alertExperimental Treatment1 Intervention
Participants will receive RN alert.
Group IV: No alertActive Control1 Intervention
Participants will receive no physician alert or registered nurse (RN) alert.

Find a Location

Who is running the clinical trial?

Columbia UniversityLead Sponsor
1,433 Previous Clinical Trials
2,433,009 Total Patients Enrolled
Jason S Adelman, MD, MSPrincipal InvestigatorColumbia University
4 Previous Clinical Trials
27,305 Total Patients Enrolled
Benjamin L Ranard, MD, MSHPStudy DirectorColumbia University
1 Previous Clinical Trials
7,200 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment for this trial ongoing at present?

"As reported on clinicaltrials.gov, this specific research endeavour is no longer recruiting patients after having been initially posted November 1st 2023 and last updated October 31st 2023. However, there are currently 398 other trials that are actively seeking enrolment."

Answered by AI
~9867 spots leftby May 2025